Betacoronavirus antigens

Betacoronavirus antigens are a collection of structural proteins from viruses within the Betacoronavirus genus, including SARS-CoV, SARS-CoV-2, and MERS-CoV [1]. These antigens primarily consist of the Spike (S), Nucleocapsid (N), Membrane (M), and Envelope (E) proteins, which are essential for the viral life cycle [2]. The Spike protein is a prominent surface glycoprotein that mediates host cell entry by binding to specific receptors like ACE2 or DPP4, making it the central target for neutralizing antibodies and vaccine development [3]. The Nucleocapsid protein is involved in viral RNA packaging and is a major target for diagnostic testing due to its high expression and immunogenicity [4]. Therapeutic interventions targeting these antigens include monoclonal antibodies that block viral attachment and vaccines that prime the immune system to recognize these proteins [5]. A significant challenge in targeting these antigens is the high rate of mutation in RNA viruses, which leads to the emergence of variants that can evade existing medical countermeasures [6]. Consequently, ongoing surveillance and the development of broad-spectrum or variant-specific agents are necessary to maintain therapeutic efficacy [7].

Other names

Beta-CoV antigensSARS-CoV-2 antigensMERS-CoV antigensSARS-CoV antigensCoronavirus structural proteins

Neutralization of viral entry by blocking the interaction between the viral spike protein and host cell receptors; induction of adaptive immune responses through vaccination.